Ardelyx reported $110.33M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Amgen USD 9.9B 340M Dec/2025
Ardelyx USD 110.33M 12.67M Sep/2025
aTyr Pharma USD 190K 2.03M Sep/2025
Corcept Therapeutics USD 207.6M 13.2M Sep/2025
Sanofi EUR 12.2B 3.19B Dec/2025
TG Therapeutics USD 161.7M 20.6M Sep/2025
United Therapeutics USD 799.5M 900K Sep/2025